NEW YORK (GenomeWeb News) – Novartis' genomics research arm will collaborate with the Juvenile Diabetes Research Foundation (JDRF) in a drug discovery and development program focused on Type 1 diabetes, JDRF said on Wednesday.

The Genomics Institute of the Novartis Foundation (GNF) will collaborate with JDRF in a four-year program that will be overseen by a review committee made up of GNF and JDRF members and by a scientific advisory board and JDRF volunteers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.